AGM
Alpine Global Management’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $42M | Hold |
2,626,692
| – | – | 9.47% | 3 |
|
2025
Q1 | $44.9M | Sell |
2,626,692
-1,691,116
| -39% | -$28.9M | 11.88% | 2 |
|
2024
Q4 | $107M | Buy |
4,317,808
+2,435,104
| +129% | +$60.3M | 13.99% | 2 |
|
2024
Q3 | $53.7M | Sell |
1,882,704
-25,000
| -1% | -$713K | 12.99% | 1 |
|
2024
Q2 | $50.4M | Buy |
1,907,704
+25,000
| +1% | +$660K | 8.76% | 1 |
|
2024
Q1 | $60.8M | Buy |
1,882,704
+484,332
| +35% | +$15.6M | 11.78% | 1 |
|
2023
Q4 | $58.9M | Buy |
1,398,372
+145,898
| +12% | +$6.15M | 16.09% | 1 |
|
2023
Q3 | $48.1M | Sell |
1,252,474
-187,070
| -13% | -$7.18M | 11.09% | 3 |
|
2023
Q2 | $27.3M | Hold |
1,439,544
| – | – | 7.52% | 2 |
|
2023
Q1 | $22.3M | Sell |
1,439,544
-60,456
| -4% | -$938K | 8.67% | 3 |
|
2022
Q4 | $26.6M | Sell |
1,500,000
-2,848,017
| -66% | -$50.6M | 8.85% | 2 |
|
2022
Q3 | $24.3M | Sell |
4,348,017
-100,000
| -2% | -$558K | 5.68% | 4 |
|
2022
Q2 | $17.3M | Buy |
4,448,017
+586,228
| +15% | +$2.29M | 4.39% | 4 |
|
2022
Q1 | $21.3K | Buy |
3,861,789
+854,789
| +28% | +$4.71K | 4.82% | 3 |
|
2021
Q4 | $25.6M | Buy |
3,007,000
+6,800
| +0.2% | +$57.9K | 3.77% | 1 |
|
2021
Q3 | $26.1M | Buy |
3,000,200
+1,000,200
| +50% | +$8.69M | 5.92% | 2 |
|
2021
Q2 | $21.1M | Buy |
2,000,000
+903,022
| +82% | +$9.54M | 2.88% | 9 |
|
2021
Q1 | $17.6M | Buy |
+1,096,978
| New | +$17.6M | 1.69% | 18 |
|